Core Insights - Bread Financial Holdings, Inc. (BFH) shares are trading at a significant discount compared to the Zacks Financial - Miscellaneous Services industry, with a forward price-to-earnings multiple of 6.28X versus the industry average of 24.85X [1] - The company has a market capitalization of $2.55 billion and an average trading volume of 0.6 million shares over the last three months [1] Growth Projections - The Zacks Consensus Estimate for BFH's 2025 earnings per share indicates a year-over-year increase of 9.6%, with revenues projected at $3.87 billion, reflecting a 0.8% improvement [5] - For 2026, earnings per share and revenues are expected to increase by 6.1% and 3.4%, respectively, compared to 2025 estimates [5] Analyst Sentiment - One of three analysts covering BFH has raised estimates for 2025, and three of seven analysts have raised estimates for 2026 in the past 60 days, leading to a 4.1% and 1.8% increase in the Zacks Consensus Estimate for 2025 and 2026 earnings, respectively [7] Credit Sales and Strategic Investments - BFH anticipates credit sales growth driven by strong consumer spending, new partnerships, and holiday demand, with average loans expected to rise alongside higher credit sales [9][13] - The company is making strategic investments in digital innovation, technology, and marketing to drive growth [15] Financial Metrics - BFH's return on invested capital over the trailing 12 months was 9.7%, outperforming the industry average of 5.1% [12] - The company has been strengthening its balance sheet and reducing debt, with plans to pay down $100 million in 2026 bonds this year [16] Shareholder Value - BFH is focused on returning value to shareholders through share repurchases and intends to increase its focus on buybacks and mergers and acquisitions [17] - The stock has a favorable VGM Score of A, indicating attractive value, growth, and momentum compared to peers [18] Valuation and Market Position - The average target price for BFH, based on short-term price targets from 15 analysts, is $71 per share, suggesting a potential upside of 27.45% from the last closing price [10] - Higher return on capital, favorable growth estimates, and attractive valuations are expected to benefit BFH in the long term [19]

Market Overview - International equities showed mixed results in Q3 2025, with the MSCI EAFE Index rising 4.8%, driven by Asian markets and Canada, while Europe Ex U.K. underperformed [3] - The MSCI Emerging Markets Index advanced 10.6%, supported by a 20.7% rally in China, which constitutes 30% of that benchmark [3] - European markets experienced a slowdown in momentum due to inflation remaining above the European Central Bank's target, with a September reading of 2.2% [4] Economic Conditions - Japan's GDP grew modestly in Q2, aided by tourism, while manufacturing activity remained restrained [5] - The People's Bank of China cut key lending rates in July to address weaknesses in the real estate sector and sluggish consumer demand, with Q2 GDP growth at 5.2% year over year [5] Investment Strategy - The MSCI EAFE Value Index outperformed the MSCI EAFE Growth Index by over 500 basis points in Q3, with value stocks leading growth by more than 1,300 basis points year to date [6] - The ClearBridge International Growth Strategy maintained pace with its core MSCI EAFE benchmark, with sector positioning in IT and financials creating headwinds [12] Company Performance - London Stock Exchange faced a decline due to AI concerns impacting its desktop and data business, while Adyen's revenue missed expectations [13] - Banco Santander was acquired for its streamlined operations and cost-cutting measures, expected to improve profitability [14] - HSBC is well-positioned for growth in Asian wealth management, benefiting from inflows of mainland Chinese money [15] - KBC Group's strong capital position allows for capital distributions or acquisitions, with growing assets under management [16] Sector Contributions - Health care sector saw solid contributions, particularly from European biotechs Argenx and UCB, driven by strong sales and positive clinical trial results [20] - The strategy expanded into the Chinese biotechnology sector with the purchase of WuXi AppTec, known for efficient drug development [21] Portfolio Adjustments - The strategy added 10 positions while exiting 13, with significant purchases in financials and health care, including Prysmian, which is poised for growth in the power cables industry [22] - Softbank trades at a discount to its NAV, holding stakes in key technology companies [23] - Celestica is positioned for growth in AI infrastructure, with expected annual revenue growth of over 20% [24] Outlook - The regions of investment are making progress on growth and equity-friendly policies, with forecasts for double-digit EPS growth in the pan-European Stoxx 600 [27] - Emerging markets are outperforming developed markets, with a focus on China’s growth potential in AI and biotechnology [28][32]

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a growth stock that can live up to its true potential can be a tough task.In addition to volatility, these stocks carry above-average risk by their very nature. Also, one could end up losing from a stock whose growth story is actually over or nearing its end.However, the task of finding cutting-edge growth stocks is made ...

Core Viewpoint - Growth stocks are appealing due to their potential for above-average financial growth, but identifying strong growth stocks can be challenging due to inherent volatility and risks [1] Group 1: Company Overview - ASICS Corporation Unsponsored ADR (ASCCY) is highlighted as a recommended growth stock based on its favorable Growth Score and top Zacks Rank [2] - The company has a historical EPS growth rate of 76.8%, with projected EPS growth of 50.9% this year, significantly outperforming the industry average of 15.1% [5] Group 2: Key Metrics - The asset utilization ratio for ASICS Corporation is 1.43, indicating that the company generates $1.43 in sales for every dollar in assets, compared to the industry average of 1.02, showcasing higher efficiency [7] - Sales for ASICS Corporation are expected to grow by 23.2% this year, while the industry average is projected at 0% [8] Group 3: Earnings Estimates - The current-year earnings estimates for ASICS Corporation have been revised upward, with the Zacks Consensus Estimate increasing by 7.5% over the past month [9] - The combination of strong earnings estimate revisions and a Growth Score of A positions ASICS Corporation favorably for potential outperformance [10][11]

Core Viewpoint - Investors are increasingly seeking growth stocks that demonstrate above-average growth potential, with Kamada (KMDA) identified as a promising candidate due to its favorable growth metrics and strong Zacks Rank [2][10]. Earnings Growth - Earnings growth is a critical factor for growth investors, with double-digit growth being highly desirable. Kamada's projected EPS growth for this year is 57.3%, significantly surpassing the industry average of 18.3% [4][5]. Asset Utilization Ratio - Kamada's asset utilization ratio stands at 0.46, indicating that the company generates $0.46 in sales for every dollar in assets, which is higher than the industry average of 0.31, showcasing better efficiency in asset utilization [6]. Sales Growth - The company's sales are expected to grow by 12.4% this year, in stark contrast to the industry average of 0%, highlighting Kamada's strong sales growth potential [7]. Earnings Estimate Revisions - There has been a positive trend in earnings estimate revisions for Kamada, with the current-year earnings estimates increasing by 4.4% over the past month, indicating favorable market sentiment [8]. Overall Positioning - Kamada has achieved a Growth Score of B and a Zacks Rank of 2, positioning it well for potential outperformance in the growth stock category, making it an attractive option for growth investors [10].

Core Insights - JR Research is recognized as a top analyst in technology, software, and internet sectors, focusing on growth and GARP strategies [1] - The investment approach emphasizes identifying attractive risk/reward opportunities with strong price action to generate alpha above the S&P 500 [1][2] - The investment group Ultimate Growth Investing specializes in high-potential opportunities across various sectors, targeting stocks with robust fundamentals and turnaround potential [3] Investment Strategy - The focus is on growth investing opportunities that offer significant upside potential while avoiding overhyped and overvalued stocks [2] - The strategy includes capitalizing on battered stocks that have substantial recovery possibilities [2] - The investment outlook typically spans 18 to 24 months for the thesis to materialize [3] Group Characteristics - Ultimate Growth Investing is designed for investors looking to capitalize on growth stocks with strong fundamentals and buying momentum [3] - The group emphasizes turnaround plays at highly attractive valuations [3]

Core Viewpoint - The Federal Reserve's decision to cut rates has prompted a focus on value investment opportunities, particularly in growth and dividend income strategies [1]. Group 1: Investment Strategy - The strategy emphasizes creating a portfolio that prioritizes compounding dividend income and growth, aiming for an easy retirement [1]. - Monthly dividend income is a key component of the strategy, with a focus on reinvestment and annual increases [1]. Group 2: Market Focus - While the market is currently fixated on the A.I. boom, there are several areas expected to perform well due to the rate cuts [1].

Core Insights - JR Research is recognized as a top analyst by TipRanks and Seeking Alpha, focusing on technology, software, internet, growth, and GARP investing [1][2] - The investment strategy emphasizes identifying attractive risk/reward opportunities with robust price action to generate alpha above the S&P 500 [1][2] - The investment group Ultimate Growth Investing specializes in high-potential opportunities across various sectors, focusing on growth stocks with strong fundamentals and turnaround plays [3] Investment Strategy - The approach combines price action analysis with fundamental investing, avoiding overhyped stocks while targeting battered stocks with recovery potential [2] - The investment outlook is typically 18 to 24 months for the thesis to materialize, aiming for robust growth potential [3] - The group is designed for investors looking to capitalize on growth stocks at attractive valuations, emphasizing buying momentum [3]

Core Insights - JR Research is recognized as a top analyst in technology, software, and internet sectors, focusing on growth and GARP strategies [1] - The investment approach emphasizes identifying attractive risk/reward opportunities with robust price action to generate alpha above the S&P 500 [1][2] - The investment group Ultimate Growth Investing specializes in high-potential opportunities across various sectors, targeting stocks with strong growth potential and turnaround plays [3] Investment Strategy - The focus is on growth investing opportunities that present significant upside potential while avoiding overhyped and overvalued stocks [2] - The strategy combines price action analysis with fundamental investing to capitalize on battered stocks with recovery possibilities [2] - The investment outlook typically spans 18 to 24 months for the thesis to materialize [3] Group Characteristics - Ultimate Growth Investing is designed for investors looking to capitalize on growth stocks with strong fundamentals and buying momentum [3] - The group targets highly attractive valuations for turnaround plays and robust growth stocks [3]

Core Viewpoint - Growth stocks are appealing due to their potential for above-average financial growth, but identifying strong candidates involves navigating inherent risks and volatility [1] Earnings Growth - Marubeni Corp. has a historical EPS growth rate of 4.2%, but projected EPS growth for this year is 14.2%, significantly surpassing the industry average of 8.6% [5] Cash Flow Growth - The year-over-year cash flow growth for Marubeni is currently 4%, which is notably higher than the industry average of -9.5% [6] - Over the past 3-5 years, Marubeni's annualized cash flow growth rate has been 79.1%, compared to the industry average of 4.4% [7] Earnings Estimate Revisions - The current-year earnings estimates for Marubeni have increased, with the Zacks Consensus Estimate rising by 2.8% over the past month [9] Overall Assessment - Marubeni holds a Zacks Rank of 2 (Buy) and a Growth Score of B, indicating it is a strong candidate for growth investors [10][11]